SEARCH

SEARCH BY CITATION

References

  • ADAMS, M.D., CHAIT, L.D. & EARNHARDT, J.T. (1976). Tolerance to the cardiovascular effects of Δ9-tetrahydrocannabinol in the rat. Br. J. Pharmacol., 56, 4348.
  • BENOWITZ, N.L. & JONES, R.T. (1975). Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin. Pharmacol. Ther., 18, 287297.
  • BENOWITZ, N.L., ROSENBERG, J., ROGERS, W., BACHMAN, J. & JONES, R.T. (1979). Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: Autonomic nervous mechanisms. Clin. Pharmacol. Ther., 25, 440446.
  • BIRMINGHAM, M.K. (1973). Reduction by Δ9-tetrahydrocannabinol in the blood pressure of hypertensive rats bearing regenerated adrenal glands. Br. J. Pharmacol., 48, 169171.
  • CAVERO, I., LOKHANDWALA, M.F., BUCKLEY, J.P. & JANDHYALA, B.S. (1974). The effect of (−)-Δ9-trans-tetrahydrocannabinol on myocardial contractility and venous return in anesthetized dogs. Eur. J. Pharmacol., 29, 7482.
  • CAVERO, I., SOLOMON, T., BUCKLEY J.P. & JANDHYALA, B.S. (1973a). Studies on the bradycardia induced by (−)-Δ9-trans-tetrahydrocannabinol in anesthetized dogs. Eur. J. Pharmacol., 22, 263269.
  • CAVERO, I., SOLOMON, T., BUCKLEY J.P. & JANDHYALA, B.S. (1973b). Studies on the hypotensive activity of (−)-Δ9-trans-tetrahydrocannabinol in anesthetized dogs. Res. Comm. Chem. Pathol. Pharmacol., 6, 527540.
  • COMPTON, D.R., HARRIS, L.S., LICHTMAN, A.H. & MARTIN, B.R. (1996). Marihuana. In Pharmacological Aspects of Drug Dependence. Handbook of Experimental Pharmacology. eds. Schuster, C.R. & Kuhar, M.J. pp. 83158. Springer: Heidelberg.
  • DEWEY, W.L. (1986). Cannabinoid pharmacology. Pharmacol. Rev., 38, 151178.
  • ESLER, M., JENNINGS, G., LAMBERT, G., MEREDITH, I., HORNE, M. & EISENHOFER, G. (1990). Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol. Rev., 70, 963985.
  • ESTRADA, U., BRASE, D.A., MARTIN, B.R. & DEWEY, W.L. (1987). Cardiovascular effects of Δ9- and Δ9(11)-tetrahydrocannabinol and their interaction with epinephrine. Life Sci., 41, 7987.
  • FELDER, C.C., JOYCE, K.E., BRILEY, E.M., MANSOURI, J., MACKIE, K., BLOND, O., LAI, Y., MA, A.L. & MITCHELL, R.L. (1995). Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Molec. Pharmacol., 48, 443450.
  • FREDERICKS, A.B., BENOWITZ, N.L. & SAVANAPRIDI, C.Y. (1981). The cardiovascular and autonomic effects of repeated administration of Δ-9-tetrahydrocannabinol to rhesus monkeys. J. Pharmacol. Exp. Ther., 216, 247253.
  • GRAHAM, J.D.P. & LI, D.M.F. (1973). Cardiovascular and respiratory effects of cannabis in cat and rat. Br. J. Pharmacol., 49, 110.
  • GRIFFIN, G., FERNANDO, S.R., ROSS, R.A., MCKAY, N.G., ASHFORD, M.L.J., SHIRE, D., HUFFMAN, J.W., YU, S., LAINTON, J.A.H. & PERTWEE, R.G. (1997). Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur. J. Pharmacol., 339, 5361.
  • HOWLETT, A.C. (1995). Pharmacology of cannabinoid receptors. Ann. Rev. Pharmacol. Toxicol., 35, 607634.
  • HUESTIS, M.A., SAMPSON, A.H., HOLICKY, B.J., HENNINGFIELD, J.E. & CONE, E.J. (1992). Characterization of the absorption phase of marijuana smoking. Clin. Pharmacol. Ther., 52, 3141.
  • ISHAC, E.J.N., JIANG, L., LAKE, K.D., VARGA, K., ABOOD, M.E. & KUNOS, G. (1996). Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol., 118, 20232028.
  • JANDHYALA, B.S. & HAMED, A.T. (1978). Pulmonary and systemic hemodynamic effects of Δ9-tetrahydrocannabinol in conscious and morphine-chloralose-anesthetized dogs: anesthetic influence on drug action. Eur. J. Pharmacol., 53, 6368.
  • KAWASAKI, H., WATANABE, S. & UEKI S. (1980). Effects of chronic administration of Δ9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in freely moving rats. Eur. J. Pharmacol., 65, 6369.
  • KUSTER, J.E., STEVENSON, J.I., WARD, S.J., D'AMBRA, T.E. & HAYCOCK, D.A. (1993). Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther., 264, 13521363.
  • LAKE, K.D., COMPTON, D.R., VARGA, K., MARTIN, B.R. & KUNOS, G. (1997a). Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors. J. Pharmacol. Exp. Ther., 281, 10301037.
  • LAKE, K.D., MARTIN, B.R., KUNOS, G. & VARGA, K. (1997b). Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension, 29, 12041210.
  • MAILLEUX, P. & VANDERHAEGHEN, J.J. (1992). Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience, 48, 655668.
  • MALINOWSKA, B., GODLEWSKI, G., BUCHER, B. & SCHLICKER, E. (1997). Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 197202.
  • MARTIN, B.R. (1986). Cellular effects of cannabinoids. Pharmacol. Rev., 38, 4574.
  • MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, B.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561564.
  • MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 6165.
  • OSGOOD, P.F. & HOWES, J.F. (1977). Δ9-tetrahydrocannabinol and dimethyl-heptylpyran induced tachycardia in the conscious rat. Life Sci., 21, 13291336.
  • PERTWEE, R.G. (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther., 74, 129180.
  • PERTWEE, R.G., STEVENSON, L.A., ELRICK, D.B., MECHOULAM, R. & CORBETT, A.D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol., 105, 980984.
  • RANDALL, M.D., ALEXANDER, S.P.H., BENNETT, T., BOYD, E.A., FRY, J.R., GARDINER, S.M., KEMP, P.A., MCCULLOCH, A.I. & KENDALL, D.A. (1996). An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Comm., 229, 114120.
  • RANDALL, M.D. & KENDALL, D. A. (1997). Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur. J. Pharmacol., 335, 205209.
  • RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIE, P., BRELIERE, J.C. & LE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240244.
  • SHOWALTER, V.M., COMPTON, D.R., MARTIN, B.R. & ABOOD, M.A. (1996). Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 278, 989999.
  • STARK, P. & DEWS, P.B. (1980). Cannabinoids. II. Cardiovascular effects. J. Pharmacol. Exp. Ther., 214, 131138.
  • STEIN, E.A., FULLER, S.A., EDGEMOND, W.S. & CAMPBELL, W.B. (1996). Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. Br. J. Pharmacol., 119, 107114.
  • SZABO, B., HEDLER, L., LICHTWALD, K. & STARKE, K. (1987). ACTH increases noradrenaline release in pithed rabbits with electrically stimulated sympathetic outflow. Eur. J. Pharmacol., 136, 391399.
  • SZABO, B. & SCHULTHEISS, A. (1990). Desipramine inhibits sympathetic nerve activity in the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 469476.
  • SZABO, B., URBAN, R., LIMBERGER, N. & STARKE, K. (1995). Cardiovascular effects of agmatine, a ‘clonidine-displacing substance’, in conscious rabbits. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 268273.
  • SZABO, B., URBAN, R. & STARKE, K. (1993). Sympathoinhibition by rilmenidine in conscious rabbits: involvement of α2-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 593600.
  • URBAN, R., SZABO, B. & STARKE, K. (1995). Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304. Eur. J. Pharmacol., 282, 2937.
  • VARGA, K., LAKE, K.D., HUANGFU, D., GUYENET, P.G. & KUNOS, G. (1996). Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension, 28, 682686.
  • VARGA, K., LAKE, K., MARTIN, B.R. & KUNOS, G. (1995). Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol., 278, 279283.
  • VIDRIO, H., SANCHEZ-SALVATORI, M.A. & MEDINA, M. (1996). Cardiovascular effects of (−)-11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl in rats. J. Cardiovasc. Pharmacol., 28, 332336.
  • VOLLMER, R.R., CAVERO, I., ERTEL, R.J., SOLOMON, T.A. & BUCKLEY, J.P. (1974). Role of the central autonomic nervous system in the hypotension and bradycardia induced by (−)-Δ9-trans-tetrahydrocannabinol. J. Pharm. Pharmacol., 26, 186192.